AR and hepatocellular carcinoma: For instance, a negative correlation between AR and PD-L1 expression was reported in tumors from patients with hepatocellular carcinoma, and increased lymphocyte infiltration was observed in AR- negative tumors treated with anti-PD-L1 drugs compared to AR-positive tumors (75).